In the BioHarmony Drug Report Database
Oxiconazole
Oxistat, Vfend (oxiconazole) is a small molecule pharmaceutical. Oxiconazole was first approved as Oxistat on 1988-12-30. It is used to treat cutaneous candidiasis, mycoses, tinea pedis, and tinea versicolor in the USA. It has been approved in Europe to treat aspergillosis, bacterial infections and mycoses, candidiasis, and mycoses.
Trade Name
|
Vfend |
|---|---|
Common Name
|
oxiconazole |
ChEMBL ID
|
CHEMBL1262 |
Indication
|
aspergillosis, bacterial infections and mycoses, candidiasis, cutaneous candidiasis, mycoses, tinea pedis, tinea versicolor |
Drug Class
|
Systemic antifungals (miconazole type) |
Image (chem structure or protein)